Landmark study to improve global osteo care standards

Nearly 60,000 women aged 55 years and older have enrolled in a landmark, multi-national study that will focus on the management of osteoporosis across the globe. Launch of the Global Longitudinal Registry of Osteoporosis in Women (GLOW) was announced at the Eighth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis in Istanbul, Turkey. This groundbreaking observational trial (registry) in osteoporosis aims to gain insights to improve the standard of care for postmenopausal women at risk of the disease.